Discover Antibiotic Stewardship

^{*AMR mortality projection compared to leading causes of death worldwide in 2014}

Help determine if antibiotics are needed or if certain bacterial infections are resolving.
 

The Elecsys BRAHMS PCT solution aids in assessing the mortality risk of patients fighting sepsis and guiding antibiotic decision-making for patients with lower respiratory tract infections, like pneumonia, bronchitis, COPD and sepsis.^8,9

Timely and cost-effective molecular solutions for improved HAI management
 

The cobas MRSA/SA and Cdiff tests provide provide excellent performance and broad coverage to increase confidence in HAI testing. Run on the fully automated cobas 4800 system, these assays may help your institution control infections and costs.

✓ Decrease transmission

✓ Reduce antibiotic use over time

References

^{1 The Review on Antimicrobial Resistance. “Tackling Drug-Resistant Infections Globally: Final Report and Recommendations.” May 2016, https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf (accessed September 25, 2017).}

^{2 Centers for Disease Control and Prevention. “1 in 3 antibiotic prescriptions unnecessary.” CDC Newsroom. https://www.cdc.gov/media/releases/2016/p0503-unnecessary-prescriptions.html (accessed February 6, 2018).}

^{3 Centers for Disease Control and Prevention. “The Core Elements of Hospital Antibiotic Stewardship Programs.” https://www.cdc.gov/antibiotic-use/healthcare/implementation/core-elements.html (accessed February 6, 2018).}

^{4 Magill SS, O'Leary E, Janelle SJ, et al. Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals. N Engl J Med 2018; 379:1732-1744. https://www.nejm.org/doi/full/10.1056/NEJMoa1801550. Accessed November 12, 2018..}

^{5 National Quality Forum. “National Quality Partners Playbook: Antibiotic Stewardship in Acute Care.” http://www.qualityforum.org/Publications/2016/05/National_Quality_Partners_Playbook__Antibiotic_Stewardship_in_Acute_Care.aspx (accessed February 6, 2018).}

^{6 Hansen, Glen T., Johanna Moore, Emily Herding, Tami Gooch, Diane Hirigoyen, Kevan Hanson and Marcia Deike. (2018). Clinical decision making in the emergency department setting using rapid PCR: Results of the CLADE study group. Journal of Clinical Virology 102:42–49.}

^{7 Peppard, W.J. and N.A. Ledeboer. (2014). Implementation of Polymerase Chain Reaction to Rule Out Clostridium Difficile Infection is Associated with Reduced Empiric Antibiotic Duration of Therapy. Hospital Pharmacy 49(7):639–643.}

^{8 Elecsys BRAHMS PCT [package insert]. Indianapolis, IN: Roche Diagnostics; 2016.}

^{9 Elecsys BRAHMS PCT antibiotic initiation and deescalation claims are pending 510(k) clearance.}

^{10 Broyles, Michael R. (October 3, 2017). “Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence.” Open Forum Infectious Diseases. Volume 4, Issue 4, ofx213. https://doi.org/10.1093/ofid/ofx213 (accessed July 24, 2018).}

^{COBAS, LIAT and ELECSYS are trademarks of Roche.}

^{© 2018 Roche Diagnostics, North America. All rights reserved.}